☆ 4.7 Article

Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer

JOURNAL OF CLINICAL ONCOLOGY (2004)

Journal

JOURNAL OF CLINICAL ONCOLOGY

Volume 22, Issue 22, Pages 4456-4462

Publisher

AMER SOC CLINICAL ONCOLOGY

DOI: 10.1200/JCO.2004.01.185

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.